Talk By Jeffrey D. Peterson- VisEn Medical: Applied Molecular Imaging from Small Animals to the Clinic
February 7, 2007
Location: IRMACS Theatre, Simon Fraser University
Presenter: Jeffrey D. Peterson, Ph.D., Director of Applied Biology, VisEn Medical
Over the past decade, breakthrough advances in genomics and proteomics have driven a fundamental evolution in our understanding of the molecular basis of disease. VisEn Medical is developing and commercializing novel imaging technologies that translate this knowledge into real-time quantitative in vivo molecular mapping of biological processes for pre-clinical animal imaging and into the clinic. The key features and benefits of VisEn's Fluorescence Molecular Tomographic (FMT) system and optical imaging probes will be presented, as well as several exemplary imaging applications spanning a broad range of disease areas including oncology, inflammation, bone and cardiovascular disease.
Short Biography of Presenter
Prior to joining VisEn in January 2006, Jeff served as a Group Leader in the Pharmacology Department of Abbott Bioresearch Center (Worcester, MA), where he managed the Arthritis Group as well as provided Pharmacology and Biology leadership of key Drug Discovery Projects. Jeff began his career as a Neuroscientist/Immunologist at Northwestern University Medical School (Chicago, IL) and the Barbara Davis Center for Childhood Diabetes (Denver, CO). He spent several years establishing expertise in mouse models of basic immune function, autoimmune and viral-induced multiple sclerosis, autoimmune diabetes, and alcohol-induced immunomodulation. Subsequently, Jeff joined Boehringer Ingelheim (Ridgefield, CT) to run the In Vivo Proof of Concept laboratory and built & led the Pharmacology Group at CuraGen Corporation, a genomics and biopharmaceutical company (Branford, CT), establishing a portfolio of experience in a wide variety of disease indications including autoimmune disease, cancer, radiotherapy-induced mucositis, kidney disease, and stroke.